Our Mission
The Antibody Innovation Alliance (AIA) works to deepen awareness and accessibility of monoclonal antibodies — a safe, proven option to help prevent serious infectious diseases.
Current gaps in public health leave patients and families with limited options to protect themselves. Americans deserve a choice in how they prevent and safeguard themselves from viral illness, supported by science.
Together alongside advocates and health professionals, AIA supports bringing mAbs to more Americans who can benefit from this transformative technology.